ReviewFrontiers in medicine2022

Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?

Paolo Solidoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.